AllianceRx Walgreens Prime Studies Adherence in Cystic Fibrosis, Ulcerative Colitis/Crohn's Disease Patients
ORLANDO, Fla., June 1, 2022. AllianceRx Walgreens Prime and Walgreens recently announced results from separate research studies exploring the impact of adherence on hospitalizations and medical costs as they related to cystic fibrosis (CF) and... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 1, 2022 Category: Pharmaceuticals Source Type: clinical trials

A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)
Condition:   Crohn's Disease Intervention:   Sponsor:   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2022 Category: Research Source Type: clinical trials

Efficacy of Ustekinumab-based Integrated Medicine Therapy in Patients With Symptomatic Stricturing Crohn's Disease
Conditions:   Crohn Disease;   Stricture; Bowel;   Intestinal Stricture Intervention:   Drug: Ustekinumab Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Sixth Affiliated Hospital, Sun Yat-sen University;   Second Affiliated Hospital of Soochow University;   Chongqing Renji Hospital, University of Chinese Academy of Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2022 Category: Research Source Type: clinical trials